IRIDEX Corporation

Equities

IRIX

US4626841013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 02:00:01 29/05/2024 am IST			5-day change	1st Jan Change
2.47 ^USD	+0.82%		-8.18%	-12.10%

24/05	IRIDEX Corporation Appoints Patrick Mercer as Its President	CI
14/05	Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024

IRIDEX Corporation Announces the Resignation of Scott A Shuda from the Board, the Compensation Committee of the Board and the Nominating and Governance Committee of the Board

April 22, 2017 at 02:13 am IST

On April 21, 2017, Scott A Shuda resigned from the IRIDEX Corporation's Board, the Compensation Committee of the Board and the Nominating and Governance Committee of the Board, in each case effective as of April 21, 2017.

Latest news about IRIDEX Corporation

IRIDEX Corporation Appoints Patrick Mercer as Its President	25/05	CI
Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024	15/05
Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, vs. Street Est of $12M	15/05	MT
Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024	27/03
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M	27/03	MT
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/03	CI
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter Ended December 30, 2023	27/03	CI
North American Morning Briefing : Markets Steady -2-	26/03	DJ
Iridex Corporation Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust	24/01	CI
Iridex Corporation Launches New Iridex 532 and Iridex 577 Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma	12/01	CI
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	27/11	CI
Transcript : IRIDEX Corporation, Q3 2023 Earnings Call, Nov 14, 2023	15/11
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q3 Revenue $12.9M, vs. Street Est of $13.5M	15/11	MT
IRIDEX Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
IRIDEX Corporation Withdraws Previously Announced Guidance for 2023	15/11	CI
Wall Street Set to Open Mixed Ahead of Federal Reserve Meeting	01/11	MT
IRIDEX Hires Advisers to Explore Strategic Alternatives	30/23/30	MT
Iridex Announces Strategic Review to Unlock Shareholder Value	30/23/30	CI
Transcript : IRIDEX Corporation, Q2 2023 Earnings Call, Aug 10, 2023	11/23/11
IRIDEX Corporation Reports Earnings Results for the Second Quarter and Six Months Ended July 01, 2023	11/23/11	CI
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q2 Revenue $12.9M, vs. Street Est of $14.2M	11/23/11	MT
IRIDEX Corporation Provides Revenue Guidance for the Year 2023	11/23/11	CI
IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell Microcap Value Index	23/23/23	CI
IRIDEX Corporation(NasdaqGM:IRIX) dropped from Russell 3000E Value Index	23/23/23	CI
Transcript : IRIDEX Corporation, Q1 2023 Earnings Call, May 11, 2023	12/23/12

Chart IRIDEX Corporation

Duration

Period

More charts

Company Profile

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Sector

Advanced Medical Equipment & Technology

Calendar

18/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for IRIDEX Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.47 USD

Average target price

2 USD

Spread / Average Target

-19.03%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
IRIDEX CORPORATION	-12.10%	3.98Cr
THERMO FISHER SCIENTIFIC	+7.87%	22TCr
DANAHER CORPORATION	+11.83%	19TCr
INTUITIVE SURGICAL, INC.	+18.87%	14TCr
BOSTON SCIENTIFIC CORPORATION	+30.03%	11TCr
SIEMENS HEALTHINEERS AG	+2.32%	6.52TCr
EDWARDS LIFESCIENCES CORPORATION	+14.15%	5.3TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.68%	5.03TCr
AGILENT TECHNOLOGIES, INC.	+6.60%	4.42TCr
GE HEALTHCARE TECHNOLOGIES INC.	+1.85%	3.64TCr

Other Advanced Medical Equipment & Technology